Nishant Gandhi

7PUBLICATIONS
107CO-AUTHORS
Molecular targetsPredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 28, 2026
Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non-Small Cell Lung Cancer.

|Apr 21, 2026
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer.

|May 07, 2025
Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations.

Ibrahim Azar, Husain Yar Khan, Sahar F Bannoura

|Apr 08, 2025
SCD1 Inhibition Blocks the AKT-NRF2-SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma.

Utsav Sen, Charles Coleman, Nishant Gandhi

|Jan 02, 2025
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes.

Justin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh

|Nov 04, 2024
ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer.

M A Voronkova, B Johnson, N Gandhi

Pageof 2

Frequent Collaborators

5 joint publications

Andrew Elliott

4 joint publications

Ari M Vanderwalde

3 joint publications

Balazs Halmos

2 joint publications

Deniz Demircioglu